Gregory K. Bell, Andrew Tepperman, and Justin Ho contributed a chapter to Global Arbitration Review’s The Guide to Damages in International Arbitration. Their chapter, entitled “Damages in Life Sciences Arbitrations,” covers disputes in the life sciences sector, with a focus on the biopharmaceutical industry. The authors outline some of the main types of disputes that are heard in life sciences arbitrations and discuss some of the life sciences-specific aspects of common analyses that are used to determine damages in these types of disputes.
To read more, click the link below.
CRA recognized in GAR’s ranking with the largest average claim size among top-10 expert firms
Global Arbitration Review’s Power Index identifies the most active and sought after expert firms in international arbitration. Every year, the GAR ranks the...